Live feed08:00:00·17dPRReleasevia QuantisnowCorbus Pharmaceuticals Announces Broad Alignment with FDA on Registration Path for CRB-701 in Second-Line HNSCC and Cervical CancerByQuantisnow·Wall Street's wire, on your screen.CRBP· Corbus Pharmaceuticals Holdings Inc.Health Care
